drug regulation
-
Patanjali case: SC directs IMA chief to publish apology in newspapers for remarks on proceedings
-
Decide on suspension of 14 Patanjali products within two weeks, Supreme Court tells Uttarakhand
-
Over 100 cough syrup-making units fail quality tests: Report
-
Patanjali told to pay Rs 50 lakh for selling camphor products in violation of Bombay HC order
-
Patanjali Ayurved stops sale of 14 products whose manufacturing licences were suspended
-
Nepal suspends sale of injection made by Indian company citing ‘serious health risks’
-
Licences of 14 Patanjali drugs revoked, Uttarakhand State Licensing Authority tells Supreme Court
-
Patanjali apology should not have to be seen through microscope, says Supreme Court
-
SC gives Patanjali one week to publicly apologise for misleading advertisements
-
SC rejects Patanjali’s second apology, says company showed ‘wilful, deliberate disobedience’
-
Uzbekistan: Indian among 23 convicted for deaths due to contaminated cough syrup
-
The story of a drug that India has failed to ban
-
Centre sounds alert on common painkiller Meftal, says it may cause adverse reaction
-
Changes to drug patent rules could affect India’s vast generic medicine industry, drive up costs
-
Distributors of contaminated Indian cough syrup paid bribes to skip mandatory test: Uzbekistan
-
WHO issues alert about another India-made syrup, flags ‘substandard’ quality
-
Centre sets deadline for pharmaceutical firms to adopt WHO’s good manufacturing practices
-
A WHO alert about Indian pharma firm failed to spark strong regulatory action, experts say
-
Gambia tightens pharmaceutical quality checks for shipments from India
-
Seven Indian cough syrups under WHO investigation into toxic medicines
-
WHO flags ‘ongoing global threat’ due to contaminated cough syrups
-
Centre bans 14 fixed dose combination drugs citing risks to patients
-
Indian-made eye drops linked to infection in Sri Lanka, drug body launches probe
-
Government tests for exported cough syrups made mandatory from June 1
-
Contaminated cough syrup made in India found in Marshall Islands and Micronesia, says WHO
-
How push from survivors and an HIV support group led to a cheaper tuberculosis drug
-
US FDA flags glaring lapses by Indian firm that made eye drops linked to vision loss and deaths
-
Drug regulators stop production at 18 firms in drive against spurious medicines
-
Uzbekistan children deaths: Marion Biotech’s manufacturing licence cancelled
-
Noida pharmaceutical firm linked to Uzbek child deaths set to lose licence
-
Three employees of Noida pharmaceutical firm linked to children deaths in Uzbekistan arrested
-
Now, Maiden Pharmaceuticals convicted for exporting substandard medicine to Vietnam
-
DGCI issues notices to Amazon, Flipkart for selling drugs without licence
-
Tamil Nadu drug controller suspends production at Global Pharma after CDC alert
-
Indian firm recalls eye drops after US flags 55 cases of adverse events, including one death
-
India’s cough syrup testing regime has a deadly blind spot
-
Act immediately to protect children from contaminated medicines, WHO urges governments
-
WHO issues alert against India-made cough syrups linked to deaths of children in Uzbekistan
-
Bombay HC quashes FDA ban on production and sale of Johnson & Johnson baby powder
-
Bombay HC orders swift action against Johnson & Johnson if its baby powder violates safety standards
-
Manufacturing activities stopped at Noida firm linked to 18 Uzbek child deaths, says health minister
-
India-made cough syrup linked to deaths in Uzbekistan sent for testing, says health minister
-
Ready to assist Uzbekistan in probe into deaths linked to India-made cough syrups, says WHO
-
Uzbekistan says 18 children died due to cough syrup made by Indian firm Marion Biotech
-
Pharmaceutical regulatory body to inspect drug manufacturing units countrywide
-
Uttarakhand bans five Patanjali ‘medicines’, cites misleading advertisements
-
Mumbai’s JJ Hospital to The Gambia: 36 years apart but a familiar story of deadly toxic drugs
-
India’s drug approval system is broken but a proposed new law does nothing to fix it
-
Drug abuse should be treated as a health and social issue – not a criminal one
-
Health ministry notifies new rules for drugs and clinical trials
-
Bad news for patients as the government weakens the drug price regulator and meddles with price caps
-
Delhi HC judgment on oxytocin calls out government on its arbitrary order
-
Delhi High Court lifts Centre’s restrictions on manufacture and sale of oxytocin by private firms
-
South Africa’s legalisation of cannabis is also a step away from its colonial and apartheid past
-
India’s ban on 328 drugs is one small step. Now, a giant leap is needed to reform the drug regulator
-
Supreme Court exempts Saridon from government’s ban on fixed dose combination drugs
-
Delhi High Court allows pharma major Wockhardt to sell its fixed dose combination drug till Tuesday
-
Health ministry bans 328 fixed dose combination drugs with immediate effect
-
Delhi High Court stays restrictions on manufacture and sale of oxytocin till October
-
Centre allows sale of Oxytocin by private retail chemists from September 1
-
India’s plan to restrict life-saving drug could endanger women during childbirth, say experts
-
Chickens in India are dosed with a very strong drug used to treat critically ill patients: Study
-
Nepal’s drug authority has asked Patanjali to recall six products for ‘substandard quality’
-
Why Amazon should keep prescription drugs off its voluminous shelves
-
Watch: John Oliver quits Trump (for a bit) and takes up marijuana, remains just as funny
-
E-pharmacies: Doctors fear rise in self-medication and abuse unless online drug sales are checked
-
India has a massive antibiotic resistance problem, and it's up to the states to solve it
-
The rising body count of the Philippines’ ‘war on drugs’
-
Reality check: Forget clinical tests, there is no proper definition of what a new AYUSH drug is
-
Could Iran be the next country to legalise cannabis and opium?